# Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

Source: https://onco.cc/trials/nct03485209/  
OnCo record `nct03485209` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Tisotumab vedotin, Pembrolizumab, Carboplatin and Cisplatin in colorectal cancer, non-small-cell lung cancer, pancreatic ductal adenocarcinoma and head and neck squamous cell carcinoma, run by Seagen, a wholly owned subsidiary of Pfizer, active and no longer recruiting.

## Summary

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors is a phase 2 interventional study registered as NCT03485209 by Seagen, a wholly owned subsidiary of Pfizer, with 350 participants enrolled, started 2018-06-25 and due to reach its primary completion in 2026-03-20. Interventions recorded: tisotumab vedotin, pembrolizumab, carboplatin and cisplatin.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT03485209
- Phase: 2
- Setting: Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors
- Sponsor: Seagen, a wholly owned subsidiary of Pfizer
- Enrolled: 350

## Sources

- ClinicalTrials.gov NCT03485209: https://clinicaltrials.gov/study/NCT03485209

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/), [Head and neck squamous cell carcinoma](https://onco.cc/cancers/head-and-neck/), [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/), [Pancreatic ductal adenocarcinoma](https://onco.cc/cancers/pancreatic/)
- drugs: [Carboplatin](https://onco.cc/drugs/carboplatin/), [Cisplatin](https://onco.cc/drugs/cisplatin/), [Pembrolizumab](https://onco.cc/drugs/pembrolizumab/), [Tisotumab vedotin](https://onco.cc/drugs/tisotumab-vedotin/)
- companies: [Genmab](https://onco.cc/companies/genmab/), [Merck & Co. (MSD)](https://onco.cc/companies/merck/)

---
JSON: https://onco.cc/api/v1/entities/nct03485209.json